Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 185   

Articles published

AZN 4,705.00 -15.50 (-0.33%)
price chart
As Deadline Passes, Will AstraZeneca plc Attract A New Bid From Pfizer Inc?
I can't reveal here whether the firm concerned was AstraZeneca or one of its FTSE 100 rivals, but I can say that the five blue chip names featured in this report currently offer an average yield of more than 4%.
Can AstraZeneca plc Beat The FTSE 100 In 2015?
Just one year ago, AstraZeneca's (LSE: AZN) (NYSE: AZN.US) share price was generally tracking the index and sentiment in the stock remained rather subdued.
AstraZeneca plc Earns Hold Rating from Berenberg Bank (AZN)  WKRB News
Credit Suisse (CS) Reaffirms Neutral Rating For AstraZeneca (AZN)  Bidness ETC
Related articles »  
2 Numbers That Could Make AstraZeneca plc A Terrific Turnaround Play
But regardless of whether you fancy stashing the cash with AstraZeneca, I strongly urge you to check out THIS BRAND NEW AND EXCLUSIVE REPORT which reveals the seven key steps you need to take to become a stock market millionaire.
AstraZeneca Seeks Judgment In Nexium Pay-For-Delay Case  Law360 (subscription)
Related articles »  
Is It Too Late To Buy November's Winners, AstraZeneca plc And Vodafone ...
November can be a gloomy month but you'll be happy if you hold shares in AstraZeneca (LSE: AZN) (NYSE: AZN.US) and Vodafone Group (LSE: VOD) (NYSE: VOD.
Related articles »  
At What Price Would AstraZeneca plc Be A Bargain Buy?
Finally, if you already have AstraZeneca tucked away in your portfolio and are in the market for more great blue-chip shares, I recommend you help yourself to this FREE Motley Fool report.
Report: Pfizer 'Unlikely' To Pursue Acquisition Of AstraZeneca  Benzinga
Related articles »  
Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN) Round 2; START
The pharmaceutical industry was the focus of intense debate earlier this year owing to potential merger between Pfizer Inc. (NYSE:PFE) and AstraZeneca plc (ADR) (NYSE:AZN). With the six month cooling period coming to its close, the question that looms ...
AstraZeneca plc Earns Hold Rating from Baader Helvea (AZN)  Intercooler
Weekly Analysts' Ratings Changes for AstraZeneca plc (AZN)  Ticker Report
Related articles »  
Neil Woodford Praises AstraZeneca plc's Prospects
Respected fund manager Neil Woodford has come out to praise the potential of AstraZeneca (LSE: AZN) (NYSE: AZN.US) this morning, after the company updated investors on its progress over the past few months.
AstraZeneca Bets Long Term on Cancer Drugs  Wall Street Journal
Pfizer Cancer Pact With Merck Shows Waning Astra Pursuit  Businessweek
Related articles »  
AstraZeneca plc And GlaxoSmithKline plc Are Strong Buys, But For Very ...
AstraZeneca's steady recovery continues apace, according to recent Q3 results, with both revenues and earnings at the higher end of expectations.
My Top 3 Pharmaceutical Stocks For 2015: GlaxoSmithKline plc, AstraZeneca ...
Investing in BTG, AstraZeneca and GlaxoSmithKline could prove to be a great move for 2015, and I think that all three companies could post excellent returns over the next year.
AstraZeneca plc: Why $4.20 Is The Magic Number
Executive compensation plans have always drawn shareholders criticism but AstraZeneca's (LSE: AZN) (NYSE: AZN.US) 'Azip' plan has been designed with shareholders in mind.
Related articles »